{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:56Z","timestamp":1791843236059,"version":"4.3.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Recent studies have shown that patients with chronic hepatitis B (CHB) have an increased prevalence of osteoporosis. However, the direct relationship between hepatitis B virus (HBV) DNA (representing the viral replication level) and bone mineral density (BMD) remains undefined. We aimed to investigate the association between HBV DNA levels and BMD in middle-aged and elderly CHB patients without prior antiviral therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study recruited 362 untreated patients with CHB (men aged \u226550 years and postmenopausal women) who underwent both HBV DNA testing and dual-energy X-ray absorptiometry (DXA) within a 6-week interval. Based on bone mineral status, patients were categorized into three groups: normal BMD, osteopenia, and osteoporosis. Multiple regression and generalized additive models (GAMs) were applied to analyze associations between HBV DNA and BMD, whereas Receiver operating characteristic (ROC) curve analysis was employed to evaluate the discriminatory ability of HBV DNA levels to distinguish patients with osteoporosis. Exploratory mediation analysis of \u03b2-CTX and CRP was performed to assess indirect statistical associations linking HBV DNA with BMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with osteoporosis had considerably higher HBV DNA levels than those with osteopenia or normal BMD. In multivariable analyses, each 1 log\n                      <jats:sub>10<\/jats:sub>\n                      IU\/mL increase in HBV DNA was associated with a 0.22-unit decrease in BMD T-score in the total cohort, with a stronger inverse association observed in males (\u03b2 = \u22120.32) than in postmenopausal females (\u03b2 = \u22120.16). GAMs revealed a continuous negative association between HBV DNA levels and BMD across the spectrum from normal bone density to osteoporosis (P for trend &amp;lt;0.001). HBV DNA demonstrated good between-group discriminatory ability for differentiating osteoporosis, with superior accuracy in males (area under the ROC curve = 0.847; optimal cut-off: 2.857 log\n                      <jats:sub>10<\/jats:sub>\n                      IU\/mL). Exploratory mediation analyses suggested that \u03b2-CTX and CRP may contribute to the association between HBV DNA and BMD in the total cohort; however, only \u03b2-CTX demonstrated a notable mediating effect in males. Notably, the direct association between HBV DNA levels and BMD remained evident across all mediating models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher HBV DNA levels are independently associated with lower BMD and demonstrate discriminatory ability for osteoporosis status in patients with CHB. Longitudinal studies are warranted to determine the predictive value of HBV DNA in predicting osteoporosis risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1714943","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:33:10Z","timestamp":1771392790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between HBV DNA levels and bone mineral density in antiviral-naive chronic hepatitis B patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Xinyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","unstructured":"Global hepatitis report 2024: action for access in low- and middle-income countries\n          \n          \n          \n          2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15867","article-title":"Increasing comorbidities in a South Korea insured population-based cohort of patients with chronic hepatitis B","volume":"52","author":"Oh","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp070341","article-title":"Clinical practice. Osteopenia","volume":"356","author":"Khosla","year":"2007","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"Jama"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2023.05.035","article-title":"Association between hepatitis B virus infection and risk of osteoporosis: A systematic review and meta-analysis","volume":"46","author":"Peng","year":"2023","journal-title":"Asian J Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1120083","article-title":"Seropositive for hepatitis B and C viruses is associated with the risk of decreased bone mineral density in adults: An analysis of studies from the NHANES database","volume":"10","author":"Tao","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.332.12099","article-title":"Low bone mineral density in chronic Hepatitis B virus infection: A case-control study","volume":"33","author":"Huang","year":"2017","journal-title":"Pakistan J Med Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1237618","article-title":"Association between resolved hepatitis B virus infection and femoral and spinal bone mineral density in American adults: a cross-sectional study","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11657-019-0590-5","article-title":"The association between hepatitis and osteoporosis: a nested case-control study using a national sample cohort","volume":"14","author":"Min","year":"2019","journal-title":"Arch Osteoporos"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.3390\/jcm13206152","article-title":"Association between chronic hepatitis B\/C and incidence of osteoporosis and bone fractures: results from a retrospective cohort study","volume":"13","author":"Loosen","year":"2024","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.12.001","article-title":"Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B","volume":"80","author":"Yip","year":"2024","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000079526","article-title":"Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection","volume":"13","author":"Buke","year":"2004","journal-title":"Med Princ Pract"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02925","article-title":"TNF-\u03b1 Directly enhances osteocyte RANKL expression and promotes osteoclast formation","volume":"10","author":"Marahleh","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan6282","article-title":"C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis","volume":"10","author":"Yang","year":"2017","journal-title":"Sci Signal"},{"key":"B17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cmet.2022.02.006","article-title":"Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression","volume":"34","author":"Lu","year":"2022","journal-title":"Cell Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-04093-8","article-title":"Red cell distribution width: a potential marker of reduced femoral neck bone mineral density in men and postmenopausal women","volume":"87","author":"Qi","year":"2024","journal-title":"Endocrine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.42646","article-title":"2022 american college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"75","author":"Humphrey","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042092","article-title":"Clinical practice. Screening for osteoporosis","volume":"353","author":"Raisz","year":"2005","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i12.1843","article-title":"Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection","volume":"11","author":"Schiefke","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30246","article-title":"Advancing age and comorbidity in a US insured population-based cohort of patients with chronic hepatitis B","volume":"69","author":"Nguyen","year":"2019","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16982","article-title":"Incidence of osteopenia or osteoporosis in asian patients with chronic hepatitis B","volume":"40","author":"Lee","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.1038\/s41598-021-89486-9","article-title":"Bone loss in hepatitis B virus-infected patients can be associated with greater osteoclastic activity independently of the retroviral use","volume":"11","author":"Dessordi","year":"2021","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17785","article-title":"Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study","volume":"59","author":"Ogawa","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae223","article-title":"Low bone mineral density as a risk factor for liver cirrhosis","volume":"110","author":"Zhang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"Bmj"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1038\/s41598-019-41674-4","article-title":"Crosssectional assessment of bone mass density in adults with hepatitis B virus and hepatitis C virus infection","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12934","article-title":"Gender disparity in chronic hepatitis B: Mechanisms of sex hormones","volume":"30","author":"Wang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06707-11","article-title":"Enhancement of hepatitis B virus replication by androgen and its receptor in mice","volume":"86","author":"Tian","year":"2012","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1038\/s41598-017-06614-0","article-title":"Estrogen regulates bone turnover by targeting RANKL expression in bone lining cells","volume":"7","author":"Streicher","year":"2017","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2017.05.009","article-title":"Bone health and impact of tenofovir treatment in men with hepatitis-B related chronic liver disease","volume":"8","author":"Sajith","year":"2018","journal-title":"J Clin Exp Hepatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu471","article-title":"Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk","volume":"211","author":"Gill","year":"2014","journal-title":"J Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12369","article-title":"Hepatic osteodystrophy and fracture risk prediction using FRAX tool in Indian patients with cirrhosis","volume":"4","author":"De","year":"2020","journal-title":"JGH Open"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.259085","article-title":"Bone turnover markers in the diagnosis and monitoring of metabolic bone disease","volume":"63","author":"Greenblatt","year":"2017","journal-title":"Clin Chem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"a021428","DOI":"10.1101\/cshperspect.a021428","article-title":"Immune response in hepatitis B virus infection","volume":"5","author":"Tan","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2023.501","article-title":"Nuclear factor-kappa B regulation of osteoclastogenesis and osteoblastogenesis","volume":"38","author":"Boyce","year":"2023","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B40","article-title":"Hepatitis B Virus Upregulates the Expression of C-reactive Protein Both in vivo and in vitro","volume":"47","author":"Hao","year":"2017","journal-title":"Ann Clin Lab Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2037","article-title":"High-sensitivity CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: the MrOS Sweden study","volume":"29","author":"Eriksson","year":"2013","journal-title":"J Bone Mineral Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1714943\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:33:11Z","timestamp":1771392791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1714943\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":41,"alternative-id":["10.3389\/fendo.2026.1714943"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1714943","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1714943"}}